Yes, Tc-99m DMSA is Retained Permanently by Proximal Renal Tubular Cells
Technetium-99m dimercaptosuccinic acid (DMSA) undergoes cortical tubular binding in the proximal renal tubules and is retained long enough to allow late-phase imaging, typically performed 1-4 hours post-injection, with acceptable images obtained even up to 24 hours in patients with advanced renal failure. 1, 2
Mechanism of Retention
The retention mechanism is well-established through recent research:
DMSA binds to metalloproteins in proximal tubular cells after being filtered through the glomeruli bound to α1-microglobulin (a ~27 kDa plasma protein) 3, 4
Uptake occurs via megalin/cubilin-mediated receptor endocytosis in the proximal tubules. Studies using megalin/cubilin-deficient knockout mice demonstrated that renal accumulation was reduced to only 11.4% of normal when these receptors were absent, confirming this is the primary uptake mechanism 3
Once internalized through this receptor-mediated endocytosis, DMSA remains bound within the cortical tubular cells with minimal excretion 4
Clinical Imaging Timeline
The retention characteristics make DMSA ideal for static cortical imaging:
- Standard imaging window: 1-4 hours post-injection 2
- Acceptable images can be obtained beginning 1-2 hours after administration 2
- In patients with advanced renal failure, satisfactory images may be obtained by delaying imaging up to 24 hours 2
- The product must be used between 10 minutes to 4 hours following reconstitution 2
Contrast with Other Renal Tracers
This retention pattern fundamentally differs from other renal imaging agents:
- Tc-99m MAG3: Excreted via tubular secretion with >95% cleared within 3 hours in normal kidney function - designed for dynamic functional studies 1
- Tc-99m DTPA: Excreted by glomerular filtration - also used for dynamic studies 1
- DMSA's cortical binding makes it uniquely suited for static parenchymal imaging rather than functional drainage assessment 1
Important Clinical Caveats
Several conditions can impair DMSA uptake despite the retention mechanism:
Proximal tubular disorders (Dent disease, Lowe syndrome, renal tubular acidosis) show markedly decreased DMSA uptake even with normal creatinine clearance, because these conditions involve defective megalin/cubilin-mediated endocytosis 5, 6, 7
Acid-base imbalance can alter DMSA uptake independent of functional renal mass 7
Tubular proteinuria: DMSA uptake is inversely proportional to urine β2-microglobulin levels 5
Hematologic disorders/lymphohistiocytosis can cause altered biodistribution with hepatic and splenic uptake 4
Practical Application
The permanent cortical retention allows DMSA to serve as a marker of functional proximal tubule endocytic activity and cortical mass 3. This makes it the gold standard for:
- Detecting renal cortical defects and scarring
- Evaluating pyelonephritis
- Assessing ectopic renal parenchyma
- Quantifying differential renal function based on cortical uptake 8, 9
The retention is sufficiently stable that planar and SPECT images obtained 2-4 hours post-injection provide reliable assessment of cortical structure without concern for washout affecting image quality 4.